Current News

Walbrook PR, which provides high quality Financial PR, Corporate Communications and Investor Relations to Small Cap and AIM listed companies, announces it is acting as strategic communications advisor for eXymes, a high growth genomics company, with a disruptive DNA/RNA extraction technology.

Walbrook is managing the company’s ongoing corporate communications.

eXymes’ products offer inexpensive, portable and easy to use enzymes, kits and devices for ultra-rapid clean DNA/RNA release without the need for a laboratory.

The technology can be used across multiple research, field and applied markets and is ideally suited for low resource sites, field applications and point of use/care testing, saving over 80% in time and labour costs and using considerably less plastic waste vs the market leader.

Paul McManus, Founder and Managing Director of Walbrook PR, said: “We are delighted to partner with eXymes at this exciting time as it looks to drive of the commercialisation of its DNA/RNA extraction technology.